Clinical supply S&OP can align demand, CDMO capacity, inventory and program trade-offs, but central planning and a clinical-focused D&OP model may work better.
- Root Causes, Part 5: The Structural Changes Clinical Supply Needs
- Rare Disease Trials: Execution Risks No One Warns You About
- Undocumented Changes Break Validated Clinical Systems
- What Happens When The Clinical Forecast Changes?
- The Patient Is In The Room. Who Is Dispensing The IP?
- When Drug Supply Has A Half-Life: Radiopharmaceutical Logistics
- AI Is Moving Clinical Supply From Forecasting To Real-Time Decision-Making
- One IP Receipt Problem Is An Exception. Four Is A Process.
ON-DEMAND WEBINARS
This panel webinar discusses the importance of clinical supply agility and how to mitigate supply chain risk that comes along with clinical supply decisions.
With so many moving parts in a clinical trial, why worry about the technology that is supposed to help manage it? In this webinar, explore five actionable and necessary strategies to leverage RTSM to simplify clinical trial operations.
Individual data points over time can provide precise drug dosing histories that enable better understanding of protocol adherence, safety, efficacy, PK/PD and a drug’s exposure-response relationship.
Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![iStock-1224887299-box-logistics-package]( "Clinical, Commercial Packaging: Delivering Next-Gen Therapies")
Clinical, Commercial Packaging: Delivering Next-Gen TherapiesSee how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.
-
![Risk-GettyImages-1364371014]( "How Long Is Your RTSM Risk Mitigation List?")
How Long Is Your RTSM Risk Mitigation List?While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.
-
![GettyImages-1391646149 technology]( "Providing Drug Supply Support In Complex Environments Through IRT")
Providing Drug Supply Support In Complex Environments Through IRTLearn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.
-
![GettyImages-1404941712-Capsules_Blister_Packaging]( "Gain Confidence In Clinical Trial Outcomes")
Gain Confidence In Clinical Trial OutcomesDelve into the ways that smart packaging integrations within clinical trial strategies can improve adherence to dosing protocols and provide a comprehensive understanding of a patient’s exposure.
-
![GettyImages-1366016941 software]( "Rethinking RTSM Software: When Bigger Isn't Better")
Rethinking RTSM Software: When Bigger Isn't BetterDon’t let legacy vendor inertia jeopardize your trial. Discover why agility and deep RTSM expertise are the new benchmarks for reducing risk and ensuring precision in clinical operations.
-
![GettyImages-2095813668-meeting-sustainability-screen-learning]( "Improving Site Efficiency With Automated Drug Resupply And Forecasting")
Improving Site Efficiency With Automated Drug Resupply And ForecastingInteractive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.
-
![GettyImages-1221576332 cell therapy]( "Logistics In Cell Therapy: Reducing Workflow Risk")
Logistics In Cell Therapy: Reducing Workflow RiskExplore key steps that should be taken when executing a cell therapy clinical trial, from selecting the right sites to optimizing study retention.
-
![Supply Chain - Getty- 1159559071]( "European Clinical Supply Planning – Balancing Cost, Flexibility, And Time")
European Clinical Supply Planning – Balancing Cost, Flexibility, And TimeBy evaluating the key parameters of a study, sponsors can identify the most effective location for packaging and distributing clinical trial supplies.
-
![iStock-1288879010-gloves-mask-box]( "5 Common Clinical Supply Chain Speedbumps")
5 Common Clinical Supply Chain SpeedbumpsClinical trials can be very complex. Discover the need to connect planning and oversight from sourcing to shipping, along with mastering requirements such as cold chain, border slowdowns, and data privacy.
-
![iStock-1088247762-risk]( "Avoiding The Risk Of A Non-Transparent Clinical Supply Solution")
Avoiding The Risk Of A Non-Transparent Clinical Supply SolutionWith the supply chain and transportation logistics disruption caused by the COVID-19 pandemic, full documentation and complete transparency becomes even more important to avoid delays and assert provenance.
- Root Causes, Part 5: The Structural Changes Clinical Supply Needs
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
